Long-term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome

Anna M. Aalbers; Paul L.A. van Daele; Virgil A.S.H. Dalm; Peter J.M. Valk; Marc H.G.P. Raaijmakers

doi:10.1002/hem3.129

Long-term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome

Anna M. Aalbers, Paul L.A. van Daele, Virgil A.S.H. Dalm, Peter J.M. Valk, Marc H.G.P. Raaijmakers^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

3 Citations (Scopus)

7 Downloads (Pure)

Original language	English
Article number	e129
Journal	HemaSphere
Volume	8
Issue number	8
DOIs	https://doi.org/10.1002/hem3.129
Publication status	Published - Aug 2024

Bibliographical note

Access to Document

10.1002/hem3.129Licence: CC BY-NC-ND

HemaSphere - 2024 - Aalbers - Long‐term genetic and clinical remissions after cessation of azacitidine treatment inFinal published version, 626 KBLicence: CC BY-NC-ND

Cite this

@article{1f1efe0316f942c9be70876508f3047f,

title = "Long-term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome",

author = "Aalbers, {Anna M.} and {van Daele}, {Paul L.A.} and Dalm, {Virgil A.S.H.} and Valk, {Peter J.M.} and Raaijmakers, {Marc H.G.P.}",

note = "{\textcopyright} 2024 The Author(s). HemaSphere published by John Wiley & Sons Ltd on behalf of European Hematology Association.",

year = "2024",

month = aug,

doi = "10.1002/hem3.129",

language = "English",

volume = "8",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "John Wiley & Sons Inc.",

number = "8",

}

TY - JOUR

T1 - Long-term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome

AU - Aalbers, Anna M.

AU - van Daele, Paul L.A.

AU - Dalm, Virgil A.S.H.

AU - Valk, Peter J.M.

AU - Raaijmakers, Marc H.G.P.

PY - 2024/8

Y1 - 2024/8

UR - http://www.scopus.com/inward/record.url?scp=85200008278&partnerID=8YFLogxK

U2 - 10.1002/hem3.129

DO - 10.1002/hem3.129

M3 - Comment/Letter to the editor

C2 - 39081801

AN - SCOPUS:85200008278

SN - 2572-9241

VL - 8

JO - HemaSphere

JF - HemaSphere

IS - 8

M1 - e129

ER -

Long-term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome

Bibliographical note

Access to Document

Other files and links

Cite this